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Internalized Tau sensitizes cells to 
stress by promoting formation and 
stability of stress granules
Cecilia A. Brunello, Xu Yan & Henri J. Huttunen
Stress granules are membrane-less RNA- and RNA-binding protein-containing complexes that are 
transiently assembled in stressful conditions to promote cell survival. Several stress granule-associated 
RNA-binding proteins have been associated with neurodegenerative diseases. In addition, a close 
link was recently identified between the stress granule core-nucleating protein TIA-1 and Tau. Tau is a 
central pathological protein in Alzheimer’s disease and other tauopathies, and misfolded, aggregated 
Tau is capable of propagating pathology via cell-to-cell transmission. Here we show that following 
internalization hyperphosphorylated extracellular Tau associates with stress granules in a TIA-1 
dependent manner. Cytosolic Tau normally only weakly interacts with TIA-1 but mutations mimicking 
abnormal phosphorylation promote this interaction. We show that internalized Tau significantly 
delays normal clearance of stress granules in the recipient cells sensitizing them to secondary 
stress. These results suggest that secreted Tau species may have properties, likely related to its 
hyperphosphorylation and oligomerization, which promote pathological association of internalized Tau 
with stress granules altering their dynamics and reducing cell viability. We suggest that stress granules 
and TIA-1 play a central role in the cell-to-cell transmission of Tau pathology.
The human genome encodes at least 1500 RNA binding proteins (RBPs) that regulate RNA metabolism from 
biogenesis to transport, localization and degradation, therefore playing a crucial role in cellular homeostasis1,2. 
Remarkably, many genetic alterations in RBP-coding genes have been associated with neurodegeneration. For 
example, mutations in fused in sarcoma protein (FUS), Tar DNA-binding protein 43 (TDP-43) and heterogene-
ous nuclear ribonucleoproteins (hnRNPA1/hnRNPA2B1) alter their localization or promote aggregation, and 
have been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)3–7. Other motor 
disorders caused by mutations in RBPs include spinocerebellar ataxia-2, caused by expanded glutamine repeats 
in Ataxin-2 gene8, mutations in survival motor neuron protein (SMN) linked to spinal muscular atrophy9, and 
a mutation in TIA-1 linked to Welander distal myopathy10. In addition, cognitive impairment can be caused by 
mutations in RBPs, as is the case with mutations in the gene coding the Fragile X mental retardation protein 
(FMRP), which can cause a variety of cognitive deficits ranging from congenital mental retardation to inherited 
autism11.
A common characteristic for many RBPs is their involvement in stress granule (SG) formation or function. 
SGs are RNA granules that transiently assemble in stressful conditions to promote cell survival by blocking trans-
lation of non-essential mRNA’s and by sequestering pro-apoptotic proteins12,13. Interestingly, several studies 
have reported the presence of SG markers in pathological inclusions of several neurodegenerative disorders14. 
Also, mutations in the valosin-containing protein (VCP) gene, associated with clearance of stress granules, cause 
autosomal dominantly inherited ALS15,16 suggesting that disturbances in RNA metabolism and SG dynamics are 
involved in the pathogenesis of neurodegenerative diseases.
A SG marker and nucleating protein TIA-1 has also been found in Alzheimer’s disease neurofibrillary tangles, 
composed of hyperphosphorylated and aggregated Tau, in increasing amounts with increasing disease severity17. 
Currently, little is known about the relationship between Tau and stress granules. Moreover, despite many reports 
that indicate cell-to-cell transmission of pathological Tau species and seeding to promote degeneration (recently 
reviewed in18), the cellular mechanisms of this phenomenon remain poorly understood. In particular, how exog-
enous Tau accesses cells is still controversial; bulk endocytosis19, macropinocytosis20 and permeabilization of the 
membrane following Tau interaction with lipid rafts21 have been proposed. In this study, we show that secreted 
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Tau is localized to cytosolic stress granules after internalization. Our current results suggest that, differently from 
normal cytosolic Tau, internalized extracellular Tau associates with SGs, interferes with their normal function 
and turnover, and reduces viability of the recipient cells. TIA-1 appears to play a central role in the recruitment 
of Tau to SGs.
Results
Internalized Tau is recruited to stress granules. As we intended to use various Tau constructs, we first 
verified their expression and localization in cells. HEK293T cells were transiently transfected with non-tagged 
Tau and GLuc-tagged forms of Tau and TauE14. TauE14 is a pseudohyperphosphorylated mutant carrying 14 
phosphomimetic (serine/threonine to glutamate) mutations22, which mimic hyperphosphorylation, a known 
driver of Tau misfolding and aggregation in AD and other tauopathies. Western blot analysis showed that these 
constructs are expressed at comparable levels in HEK293T cells (Fig. 1A). When transiently transfected, wild-
type Tau constructs did not promote SG formation and associate with SGs, as shown by co-immunostaining with 
Tau-5 and TIA-1 antibodies (Fig. 1B). Cells transfected with TauE14 showed a few puncta that co-stained with 
Figure 1. Transfected and internalized extracellular Tau differ in their ability to associate with stress 
granules. (A) Expression of non-tagged Tau, Tau-GLuc1/2 and TauE14-GLuc1/2 in HEK293T cells as detected 
by Western blot. The blot picture was cropped from a larger original image, maintaining all the stained bands. 
(B) HEK293T cells transiently transfected with the above-mentioned constructs and stained with Tau-5 (green) 
and TIA-1 (red) antibodies. Arsenite (0.5 mM for 30 min) was used as a positive control for induction of stress 
granules. (C) Quantitative analysis of stress granule formation. Stress granule-positive cells were counted 
among the Tau-transfected cells. Arsenite treatment promoted stress granule-formation in all cells while 
only some Tau-transfected, and more efficiently TauE14-transfected, cells contained stress-granules (n = 3). 
(D) Resazurin-based cell viability assay with HEK293T cells transiently transfected with the Tau constructs. 
Salubrinal and arsenite were used as positive controls for stress granule induction (n = 4). (E) LDH release 
assay in HEK293T cells transfected with the Tau constructs and treated with salubrinal and arsenite as positive 
controls (n = 4). Relative LDH release was calculated from the ratio of LDH in the media and total LDH 
(from media and the cells). (F) Protein-fragment complementation assay (PCA) in HEK293T cells transiently 
transfected with TIA-1-GLuc1, Tau-GLuc2 and TauE14-GLuc2 (n = 3). (G) PCA-based coplating experiment 
to study cell-to-cell transfer of Tau. Batches of HEK293T cells were separately transfected with a single PCA 
construct (TIA-1-GLuc1, Tau-GLuc2, TauE14-GLuc2 or GSK3β -GLuc2 as a control), followed by replating the 
cells in various combinations 24 h post-transfection (n = 3). Scalebar = 10 μ m; average + /− SEM is shown;  
* * * p < 0.001; * * p < 0.01; * p < 0.05.
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Figure 2. Internalized extracellular Tau localizes to stress granules. (A) PCA from conditioned media 
collected from HEK293T transiently transfected with either mock plasmid, Tau-GLuc1, Tau-GLuc2 or Tau-
GLuc1/Tau-GLuc2. Secreted Tau dimers accumulate in fresh serum-free media (n = 3). Media was conditioned 
for 24 h with HEK293T cells expressing different forms of Tau for the subsequent experiments.  
(B) Resazurin-based cell viability assay showing decreased viability of cells exposed to Tau-GLuc1/2-containing 
media compared to the control-media exposed cells (n = 6). (C) Relative LDH release for cells exposed to Tau-
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Tau and TIA-1, while cells expressing Tau-GLuc treated with arsenite, a classical inducer of SGs, showed a prom-
inent stress granule response and also some recruitment of wildtype Tau to SGs (Fig. 1B,C).
Although arsenite induces a robust SG response – all cells resulted positive for TIA-1-positive SGs – it is toxic 
to cells via multiple mechanisms. In further experiments, we used salubrinal, an inhibitor of eIF2α dephospho-
rylation23, to promote SG formation with less toxicity24 (Fig. 1D). Assessment of cell viability with a resazurin 
reduction assay that monitors cellular metabolism showed that a 4-hour treatment with 100 μ M salubrinal did 
not significantly decrease viability compared to the untreated control cells. On the other hand, Tau transfection 
itself resulted in almost 50% decreased viability with both the wildtype and the TauE14 forms, while further 
salubrinal treatment did not further exacerbate Tau toxicity, suggesting that SG formation does not affect via-
bility in Tau-transfected cells (Fig. 1D). When cell viability was assessed by LDH release measurement, neither 
salubrinal or arsenite treatments increased LDH release, suggesting that the cell membrane remained intact in 
the experimental conditions used in this study (Fig. 1E). However, expression of Tau or TauE14 increased LDH 
release. Thus, both viability assays used, resazurin reduction and LDH release assays, showed similar effects on 
cell viability.
As a previous study suggested that TIA-1 directly interacts with Tau17, we next used a reversible 
protein-fragment complementation assay (PCA) to study the interaction of TIA-1 with Tau and TauE14 in 
live cells. Complementary fragments of Gaussia luciferase (GLuc) were tagged to TIA-1 and Tau, and the TIA-
1-GLuc1, Tau-GLuc2 and TauE14-GLuc2 constructs were coexpressed in HEK293T cells. Generation of luciferase 
is only possible if the proteins come to close proximity (<10 Å) with each other allowing folding the GLuc frag-
ments into active luciferase. As shown in Fig. 1F, when coexpressed wildtype Tau shows only weak interaction 
with TIA-1 while TauE14 shows more than 6-fold higher interaction signal. In agreement with the previous 
study17, the increased PCA signal level for TauE14/TIA-1 suggests enhanced interaction for the (pseudo)hyper-
phosphorylated Tau with TIA-1 compared to wildtype Tau.
In the light of the emerging literature of cell-to-cell propagation of Tau, we next asked if internalized extra-
cellular Tau could associate with SGs. For this purpose, we generated separate batches of cells expressing sin-
gle reporter fragments: TIA-1-GLuc1, Tau-GLuc2, TauE14-GLuc2 or the control plasmid GSK3β -GLuc2. Cells 
expressing TIA-1-GLuc1 were then coplated together with an equal number of separately transfected cells express-
ing Tau-GLuc2, TauE14-GLuc2 or GSK3β -GLuc2, and bioluminescence was measured after 24 hours. Generation 
of luminescence signal would thus be only possible if one of the expressed reporter proteins was capable of trans-
ferring to neighboring cells. While in wells containing cells expressing TIA-1-GLuc1 and GSK3β -GLuc2 the sig-
nal was nearly undetectable, there was clear luminescence signal generated in wells containing cells expressing 
TIA-1-GLuc1/Tau-GLuc2 and TIA-1-GLuc1/TauE14-GLuc2 combinations (Fig. 1G). This suggests that one of the 
reporter proteins had been secreted and internalized by the cells expressing the complementary reporter protein 
fragment. Interestingly, in the coplating assay wildtype Tau generated comparable signal to TauE14 suggesting 
that it either had better ability for cell-to-cell transfer or it had acquired a property that enhances its interaction 
with TIA-1.
We recently developed a PCA-based method for monitoring cell-to-cell transfer of Tau dimers in live 
cells25. As shown in Fig. 2A, luminescence-emitting Tau dimers are effectively secreted by HEK293T cells when 
Tau-GLuc1 and Tau-GLuc2 reporters are coexpressed. When naïve cells were exposed to either mock-transfected, 
Tau-GLuc1/2 or untagged Tau conditioned media, there was a mild but significant decrease (− 20%) in cell viabil-
ity (Fig. 2B,C), suggesting that the secreted Tau species (both GLuc-tagged and untagged native Tau) are similarly 
toxic to the cells.
Since the extracellular Tau was internalized and localized to punctate structures in the recipient cells 
(Fig. 2D–G), we used a panel of markers of cytosolic vesicles to identify the structures where internalized Tau 
localizes. Six-hour exposure of naïve recipient cells to Tau-GLuc1/2 or untagged Tau conditioned media resulted 
in similar punctate Tau-5 staining inside the cells (Fig. 2D–G). Interestingly, there was no colocalization of Tau-5 
with Rab5 (marker for early endosomes), Rab7 (marker for late endosomes) or Lamp2 (marker for lysosomes) 
GLuc1/2-containing media show slightly decreased viability compared to the control cells (n = 4).  
(D) Naïve HEK293T cells were exposed to Tau-GLuc conditioned media for 6 h and stained with Tau-5 and 
(from left to right) Rab5, Rab7 and Lamp2 antibodies to mark early endosomes, late endosomes and lysosomes, 
respectively. (E) Fluorescent TAT-TAMRA peptide was used as a marker for macropinosomes and visualized in 
live-cell imaging together with Tau-BiFC containing media, showing some colocalization. Tau-BiFC media was 
produced collecting conditioned media from HEK293T cells transfected with Tau-GFP10C and Tau-GFP11C, 
two Tau constructs carrying complementary fragments of GFP. Similar to GLuc-based PCA, generation of 
GFP signal requires Tau dimerization. (F) Naïve HEK293T cells were exposed to untagged Tau conditioned 
media for 6 h and stained with Tau-5 and SG marker TIA-1. (G) Naïve HEK293T cells exposed to Tau-GLuc1/2 
containing media for 6 h and costained with Tau-5 and SG markers TIA-1, eIF3η and TTP. (H) Quantitative 
analysis of SGs using different markers indicates that TIA-1 and eIF3η staining frequently localize with Tau 
while TTP colocalization with Tau is found in very few cells (n = 4). (I) Quantitative analysis of TIA-1-positive 
SG formation in cells conditioned with Tau-GLuc and Tau media compared to control media (n = 4).  
(J) Western blot of Tau-GLuc-transfected cell lysate and Tau-GLuc conditioned media, stained with AT8, Tau-5 
and GAPDH antibodies. Media was concentrated by 250x using filter centrifugation before loading on gel. 
The blot picture was cropped from a larger image, maintaining all the stained bands. (K) Naïve HEK293T cells 
were exposed to Tau-GLuc conditioned media for 6 h and stained with AT8 and TIA-1 antibodies, showing 
colocalization of Ser199/Ser202/Thr205-phosphorylated Tau and TIA-1 in the recipient cells. Scalebar = 10 μ m; 
average + /− SEM is shown; * * * p < 0.001; * * p < 0.005; * p < 0.05.
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(Fig. 2D). As macropinosomes were recently proposed as a major route of cellular entry for Tau20, we used a 
fluorescently labeled TAT-TAMRA peptide as a marker of macropinosomes. Since TAT-TAMRA works only in 
live-cell imaging, we used Tau-BiFC dimer-conditioned media instead of Tau-GLuc1/2. The split GFP system 
works similarly to GLuc-based PCA but the refolded GFP reporter may be less reversible25,26. For a qualitative 
localization study, the combination of Tau-BiFC with TAT-TAMRA was thus justified. As shown in Fig. 2E, cells 
exposed to Tau-BiFC-conditioned media show colocalization of GFP signal with TAT-TAMRA suggesting that 
Tau enters HEK293T cells via macropinosomes. However, it should be noted that this does not exclude the possi-
bility that other routes of entry may contribute to internalization of Tau.
As only minority of Tau-positive structures in recipient cells showed colocalization with vesicular structures, 
we reasoned that the rest of the cytosolic punctate staining might reflect the localization of internalized Tau with 
non-vesicular cellular bodies, particularly stress granules. Immunofluorescence staining revealed a significant 
colocalization of untagged Tau (Fig. 2F) and Tau-GLuc1/2 (Fig. 2G) with the SG marker TIA-1. Similar colo-
calization was also found with another SG marker eIF3η but not with TTP (Fig. 2G). While roughly 70–90% of 
cells exposed to Tau conditioned media showed SGs that costained for Tau and TIA-1 or eIF3η , only 4% of cells 
contained SGs positive for Tau and TTP (Fig. 2H). Tau internalization also clearly promoted stress granule forma-
tion in the recipient cells, as only 20% of HEK293T cells exposed to control media contained TIA-1-positive SGs 
while > 80% of cells exposed to Tau-GLuc1/2 or Tau-conditioned media contained SGs (Fig. 2I).
Figure 3. Internalized TauE14 and Tau(P301L) localize to stress granules. (A) Naïve HEK293T cells were 
exposed to TauE14-GLuc media for 6 h and stained with Tau-5 and TIA-1 antibodies. (B) Similarly to panel 
A, cells were exposed to Tau(P301L)-GLuc conditioned media and stained with Tau-5 and TIA-1 antibodies. 
(C) Quantitative analysis of TIA-1-positive SGs in cells conditioned with Tau-GLuc media, TauE14-GLuc 
and Tau(P301L)-GLuc conditioned media compared to control media (n = 4). (D) Resazurin-based cell 
viability assay for cells exposed to Tau-GLuc, TauE14-GLuc and Tau(P301L)-GLuc conditioned media (n = 4). 
Scalebar = 10 μ m; average + /− SEM is shown; * * * p < 0.001; * * p < 0.01.
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Figure 4. Internalized Tau is recruited to stress granules in N2A cells. (A) Naïve N2A cells exposed 
to Tau-GLuc conditioned media for 6 h and stained with Tau-5 and stress granule markers TIA-1, eIF3η 
and TTP. TIA-1 and eIF3η show clear colocalization with internalized Tau, while TTP does not show any. 
(B) Quantitative analysis of SG formation in cells exposed to Tau conditioned media compared to control 
media indicates that about 40% of N2A cells contained TIA-1-positive SGs following Tau uptake (n = 4). 
(C) Resazurin-based cell viability assay indicates that viability of N2A cells exposed to Tau-GLuc media was 
significantly decreased compared to cells exposed to control media (n = 8). Scalebar = 10 μ m; average + /− SEM 
is shown; * * * p < 0.001.
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Because of the differences seen between wildtype Tau and TauE14 in the transfection and the coplating con-
ditions (Fig. 1F–G), we hypothesized that wildtype Tau could undergo posttranslational modification (such as 
phosphorylation, as suggested by the phosphomimetic form of Tau) that would enhance its ability to interact with 
proteins involved in SG formation. To test this hypothesis, we concentrated Tau conditioned media and analyzed 
it by Western blotting together with the cell lysate. As expected based on previous results, the cell lysate contained 
the vast majority of total Tau protein (Tau-5 staining in Fig. 2J). However, there was a remarkable enrichment of 
Tau species phosphorylated at the AT8 epitope in the conditioned media as compared to the lysate (AT8 staining 
in Fig. 2J). Furthermore, the AT8 phosphorylated secreted Tau species were mostly SDS-stable oligomers, which 
were nearly absent from the cell lysate. Immunofluorescence staining of cells exposed to Tau conditioned media 
showed that internalized Tau associated with SGs was phosphorylated at the AT8 epitope (Fig. 2K).
In the light of these findings, we also tested if other modifications in Tau affect its SG recruitment. As shown in 
Fig. 3A,C, internalized TauE14 was recruited to SGs and also reduced viability of recipient cells. P301L mutation, 
which causes familial frontotemporal dementia via increased Tau aggregation27,28, also localized to SGs after inter-
nalization from the conditioned media (Fig. 3B,C). In HEK293T cells, we did not observe significant quantitative 
or morphological differences between the SG association of wildtype Tau, TauE14 or Tau(P301L).
Next, we examined if Tau uptake and recruitment to SGs occur also in N2A neuroblastoma cells. Figure 4A 
shows that internalized Tau is recruited to SGs positive for markers TIA-1 and EIF3η , but not with TTP, in N2A 
cells. Interestingly, while in HEK293T cells, nearly 90% of the cells were positive for TIA-1/Tau staining, only 
40% of N2A cells displayed Tau-positive SGs (Fig. 4B). Also, we observed fewer but occasionally larger SGs 
per cell in N2A cultures as compared to HEK293T cells. Despite these differences, the viability of N2A cells 
was significantly decreased (− 38%) following exposure to Tau conditioned media (Fig. 4C). These data sug-
gest that, despite minor differences uptake efficiency and SG morphology, different cell types uptake extracel-
lular Tau resulting in its recruitment to SGs and that this is associated with reduced cell viability. Moreover, 
hyperphosphorylation-induced oligomerization may be an important factor promoting the SG recruitment of 
internalized Tau species.
TIA-1 is required for stress granule recruitment of internalized Tau. Next, we further investigated 
the role of TIA-1 in the SG recruitment and the associated toxicity of Tau. First, we used RNAi to silence TIA-1 
expression in recipient cells. Knockdown efficiency of TIA-1 shRNA plasmids (shTIA-1), determined using qPCR 
Figure 5. Tau localization to stress granules requires TIA-1. (A) TIA-1 shRNA knockdown efficiency 
determined by qPCR following shRNA plasmid transfection of HEK293T cells. Levels of TIA-1 mRNA were 
normalized to GAPDH mRNA levels (n = 2). (B) TIA-1 was transiently knocked down in HEK293T cells 
(middle and right images) that were then exposed to Tau-GLuc-conditioned media and stained with Tau-5 and 
stress granule marker antibodies. The middle image shows typical cells with mostly cytosolic, non-punctate 
staining of Tau. The image on the right shows an example of a cell with SGs costaining with Tau and eIF3η .  
(C) Quantitative analysis of Tau-positive stress granule formation. SGs were present in the majority of cells 
exposed to Tau media when TIA-1 is normally expressed but were significantly decreased when TIA-1 was 
knocked down. Similar results were obtained with both TIA-1 and eIF3η staining (n = 3). (D) Resazurin-based 
cell viability assay showed that TIA-1 knockdown had no effect on cell viability per se but was able to improve 
viability in cells exposed to Tau-GLuc-conditioned media (n = 3). Scalebar = 10 μ m; average + /− SEM is 
shown; * * * p < 0.001; * * p < 0.01; * p < 0.05.
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Figure 6. Internalized Tau alters stress granule dynamics and sensitizes cells to stress. (A) Tau-GLuc-
conditioned media or 0.1 mM Salubrinal was applied to HEK293T cells for 4 h, followed by a washout with 
normal media. Cells were fixed at 4 and 20 h after the washout and stained with TIA-1 and Tau-5 antibodies. 
DBeQ (10 μ M) was used as a positive control to inhibit stress granule disassembly after the treatments.  
(B) Quantitation of immunofluorescence images: stress granule-positive cells over total cells were counted for 
each condition (n = 3). (C) Cell viability assay for the washout experiment (n = 4). (D,E) Cell viability assay 
for cells treated either with salubrinal (D) or with Tau-conditioned media (E) followed by 4 hours of recovery 
in fresh media and further treatement with 30 nM Rotenone for 6 h. In the salubrinal control cells Rotenone 
showed minimal toxicity while in cells exposed to Tau-GLuc-conditioned media Rotenone significantly 
decreased cell viability (n = 4). Scalebar = 10 μ m; average + /− SEM is shown; * * * p < 0.001.
www.nature.com/scientificreports/
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was about 50% compared to the mock-transfected cells expressing endogenous levels of TIA-1 (Fig. 5A). Recipient 
cells transfected with shTIA-1 and exposed to Tau-GLuc conditioned media showed a remarkable reduction in 
TIA-1-positive SGs and recruitment of Tau reporters to the SGs (Fig. 5B,C). When TIA-1 was only partially 
expressed, the there were significantly less cells containing Tau-positive SGs compared to control-transfected cells 
exposed to Tau conditioned media (Fig. 5C). Notably, Tau-5 staining indicated that Tau was internalized from 
the media but its distribution appeared to be less punctate and more evenly spread throughout the cytoplasm of 
the shTIA-1 cells. Immunostaining of shTIA-1-transfected cells with eIF3η showed that SG-like structures were 
still forming in the cells independently of the presence of TIA-1, and some cells contained Tau-positive SGs that 
colocalized with eIF3η (Fig. 5B, right image). However, the number of SGs that costained for Tau/TIA-1 and Tau/
eIF3η was reduced by 80% and 66%, respectively, compared to the mock-transfected cells (Fig. 5C). Importantly, 
partial absence of TIA-1 also protected recipient cells from Tau toxicity as shown by improved viability after expo-
sure to Tau-GLuc conditioned media (Fig. 5D), in line with a recently published study29. Altogether these data 
suggest that TIA-1 plays a major role in recruitment of internalized Tau to SGs and also modulates the toxicity of 
propagating Tau species.
Internalized Tau alters stress granule dynamics and sensitizes cells to stress. As abnormal SG 
function and dynamics have been implicated to contribute to pathogenesis of neurodegenerative diseases, we 
investigated the role of internalized Tau in SG clearance and dynamics. SGs normally resolve within a few hours 
from the disappearance of the stressful stimulus that promoted their formation12. When induction of SGs with 4 h 
treatment with salubrinal was followed by a 4-hour washout period, the SGs had nearly completely disappeared 
from the cytoplasm (Fig. 6A). However, in the presence of DBeQ, an inhibitor of VCP-mediated SG clearance15, 
the SGs were not effectively resolved. When the recipient cells were exposed to Tau-GLuc conditioned media for 
4 hours, followed by 4 hours washout period with fresh, non-Tau-containing media, the SGs were still present. 
Even after 20 h washout, there was a significant amount of SGs positive for both Tau and TIA-1 present in the cells 
(Fig. 6A,B). Addition of DBeQ further accentuated the SG phenotype resulting in very large Tau/TIA-1 positive 
clusters.
Surprisingly, when viability of Tau-exposed and washed cells was measured, significant increase in cell death 
was not observed, even after the 20 h washout period (Fig. 6C). We hypothesized that the while the prolonged 
presence of SGs may not directly impair cell viability, the cells may be more sensitive to secondary stress. Cells that 
had been first pretreated with Tau-GLuc conditioned media for 4 hours, followed by a 4-hour recovery period and 
then incubated with subtoxic concentration (30 nM) of rotenone30, a mitochondrial complex 1 inhibitor, showed 
a significant decrease in cell viability (Fig. 6E). Notably, similar effect was not observed in salubrinal-pretreated 
cells (Fig. 6D). The reduction in cell survival of Tau-exposed cells was stronger compared to non-Tau-pretreated 
cells receiving rotenone or to cells treated with Tau-conditioned media only. Altogether this implies that Tau 
recruitment to SGs strongly affects their normal clearance dynamics and that while prolonged presence of SGs in 
cells might not directly affect viability in short-term, it might impair the ability of cells to cope with subsequent 
stressful events.
Discussion
Many previous studies have established the ability of misfolded, pathological Tau forms to spread in a 
time-dependent manner to neuroanatomically connected unaffected brain areas31–33. Tau transmission has been 
reported to occur transsynaptically from one neuron to another34 and be facilitated by microglial packing of Tau 
into exosomes35. Very little is currently known about the cellular mechanisms that are involved in cell-to-cell 
transfer of Tau or the events and functional consequences triggered by its internalization. Existence of Tau strains 
with different cell-to-cell propagation properties has been recently reported36,37. The variety arising from Tau 
splicing and the numerous posttranslational modification sites suggest that different Tau strains may have differ-
ent properties and could propagate differently through different non-exclusive mechanisms.
A previous study showed that SG proteins TIA-1 and TTP bind to phospho-Tau and localize to neurofibrillary 
tangles in the brains of late stage AD patients and animal models of FTDP-1717. It is currently not clear whether 
TIA-1 and TTP interact with Tau under normal physiological conditions or are these interactions limited to 
pathological conditions. The experimental conditions used in our current study, based on Tau overexpression 
and resulting in secretion of hyperphosphorylated, oligomeric Tau, are more likely to mimic a pathological setting 
than normal physiological conditions. Thus, our in vitro results shed more light on how the pathological Tau spe-
cies affect the viability of cells that internalize Tau, and provide further evidence for the role SGs in propagation of 
pathology in tauopathies. While this work was under review, a separate study was published showing that TIA-1 
and Tau act synergistically to modulate degeneration of neurons, and that TIA-1 knockdown or knockout inhibits 
Tau misfolding and toxicity29.
Internalized Tau, unlike overexpressed cytosolic Tau, promotes SG formation despite the much higher abun-
dance of Tau in the cytosol. Our data indicates that modifications in Tau composition or structure have occurred 
during the secretion-uptake process, and that only the internalized Tau species (or some of them) are able to 
effectively interact with TIA-1 and promote formation of SGs. The role of TIA-1 seems critical as even a par-
tial knockdown strongly reduced Tau recruitment to SGs, without affecting internalization of Tau. Interestingly, 
the ability of wildtype Tau to interact with TIA-1 was significantly enhanced after internalization as compared 
to cytosolic, transfected Tau, if considering the relative abundance of the two proteins in the two conditions. 
Instead, TauE14, carrying 14 Ser/Thr-to-glutamate mutations mimicking hyperphosphorylation of Tau, displayed 
increased affinity towards TIA-1 inside the cells, further supporting the idea that phosphorylation regulates the 
interaction of TIA-1 and Tau. The interaction between TIA-1 and Tau seemed specific, as another classical SG 
marker, TTP, previously shown to interact with Tau in vivo17, did not colocalize with Tau-positive SGs in either 
www.nature.com/scientificreports/
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HEK293T or N2A cells. It is possible that, among the variety of proteins that constitute differentially composed 
SGs, TTP is not primarily recruited to Tau-induced SGs. Moreover, there may be cell-type differences in the sets 
of SG proteins involved or that recruitment of TTP to neurofibrillary tangles is part of a different cellular process 
that was not replicated in our in vitro system.
Interestingly, wildtype Tau, the pseudohyperphosphorylated form TauE14 and the disease-linked mutant 
Tau(P301L) appear to behave in a similar way when internalized from the media, suggesting that either the dif-
ferences between these three forms of Tau are not relevant for the uptake process and recruitment to SGs, or that 
during secretion wildtype Tau acquires novel features that promote its localization to SGs. This last hypothesis 
is supported by the result that secreted wildtype Tau was heavily phosphorylated at the AT8 epitope and con-
siderably more oligomeric compared to intracellular Tau. Although there may be other posttranslational Tau 
modifications involved, the evidence presented here suggests that hyperphosphorylation may be associated with 
the recruitment of wildtype Tau to SGs following internalization. Interestingly, it appears that either Tau hyper-
phosphorylation is coupled to the secretion process or that these cells preferentially direct those Tau species that 
are heavily phosphorylated for secretion.
In our current study, internalized Tau colocalized with the macropinosome marker TAT-TAMRA, sim-
ilarly to a previous report20, but did not colocalize with markers of early and late endosomes or lysosomes. 
Macropinosomes have recently been implicated in neurodegenerative diseases as they allow the intake of large 
structures such as prion-like protein aggregates (reviewed in38). It is likely that in our system macropinosomes 
represent the internalization mechanism of only a portion of the total Tau entering the cell. Currently, the mecha-
nism of how Tau escapes from the macropinosomes to the cytosol, a prerequisite for interaction with SG proteins, 
remains unknown. Interestingly, Tau oligomers seem to be highly surface active and may be able to disrupt the 
vesicle membrane, which could explain their escape from vesicles to the cytosol21,39.
One current hypothesis for the role of SGs in neurodegenerative diseases considers them as a pathological 
seeding point, where misfolded proteins find other low complexity proteins with aggregating domains, forming a 
nucleating core for further aggregation40,41. Several recent reports have provided further support for this hypoth-
esis by showing that RBPs FUS and hnRNPAs undergo phase transition between a liquid phase, in which the pro-
teins organize themselves into droplets, and a solid phase, which promotes aggregation and fibril assembly42–44. 
Interestingly, low complexity sequences, a common feature of both Tau and TIA-1, have a flexible secondary 
structure, but in presence of a ligand the structure becomes more rigid, possibly promoting fibrillization45. These 
nuclei that would act as a pathological seed would not behave as physiological SGs, therefore they would fail to 
be degraded and resolved, prolonging their presence in the cytoplasm. In this study, we report that following 
removal of the Tau-containing media and allowing the cells to recover from stress, persistent Tau-containing SGs 
were still detected in cells for at least up to 20 hours (longer timepoints not tested), suggesting that Tau-induced 
SGs and salubrinal-induced SGs are functionally and possibly structurally different, and undergo different clear-
ance kinetics. Such abnormally long-lasting SGs were associated with sensitization of cells to secondary stress. 
This could loosely mimic an AD or any other neurodegenerative disease scenario, where the proteinopathy and 
progressive loss of neurons develops slowly over time46, as do the clinical symptoms.
Our current data suggests that SGs may play a central role in cell-to-cell propagation of Tau species, possibly 
serving as a pathological seeding point. While this study describes a new cellular mechanism for the toxicity and 
propagation of internalized Tau through alteration of SG dynamics, future studies are required to elucidate the 
exact mechanisms underlying Tau recruitment to SGs from macropinosomes and whether there are specific Tau 
species with a particular molecular signature that preferentially promote SG formation.
Materials and Methods
Constructs. The split Gaussia princeps luciferase (GLuc) system used in this study has been previously 
described47. The original humanized GLuc plasmids were a gift from Prof. Stephen Michnick (Université 
de Montréal, Montreal, Canada). The cDNAs for Tau (human isoform 0N4R; GeneBank accession number 
BC114948) and TIA-1 cDNA (BC046812.1) were purchased from Thermo Scientific. TauE14 (the pseudohyper-
phosphorylated form of Tau) plasmid22 was a kind gift from prof. Mel B. Feany (Harvard Medical School, Boston, 
MA, USA). Tau(P301L) mutant was a gift from Dr. Karen Ashe (University of Minnesota, Minneapolis, MN, 
USA) (Addgene plasmid #46908). The hGLuc fragments were cloned to C-termini of Tau, TauE14, Tau(P301L) 
and TIA-1, separated by a (GGGGS)2SG linker in a pcDNA3.1/zeo plasmid backbone.
Pair of commercial plasmids containing the parts of the split GFP was used as the basis for cloning the bimo-
lecular fluorescence complementation (BiFC) assay plasmids (Sandia Biotech Inc., USA)48. The BiFC assay is 
based on splitting superfolder GFP into two complementary fragments encoding β -strands 1–10 (1–214 aa) and 
the 11th β -strand (215–230 aa). The GFP fragments were cloned to the Tau C-terminus.
The TIA-1 shRNA clones (TRCN0000074463, TRCN0000074464, TRCN0000074465, TRCN0000074466, 
TRCN0000074467; in pLKO.1 plasmid) were acquired from the TRC1.0 library via the Functional Genomics 
Unit Biomedicum Helsinki. All plasmids were sequenced to confirm their identity. The clone TRCN0000074465 
was used in the knockdown experiments.
Chemicals. Classic stress granule inducer (sodium arsenite), EIF2α inhibitor (salubrinal) and p97/
valosin-containing protein (VCP) inhibitor (DBeQ) were purchased from Sigma-Aldrich and used at concentra-
tion of 500 μ M, 100 μ M and 10 μ M, respectively. Rotenone was a kind gift from Dr. Timo Myöhänen (Faculty of 
Pharmacy, University of Helsinki) and used at concentration of 30 nM.
Cell culture and media production. Human embryonic kidney (HEK) 293 T cells were cultured in DMEM 
supplemented with 1% (v/v) penicillin, streptomycin and L-glutamine (Lonza) and 10% (v/v) FBS (Invitrogen) 
at 37 °C and 5% CO2 atmosphere. For Tau conditioned media production, cells were plated at a density of 9 × 106 
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cells in 10 cm plates. Transfection was performed using JetPei (Polyplus) according to manufacturer’s instruc-
tions. The culture medium was replaced 24 hours post-transfection with phenol red-free DMEM (Invitrogen) 
supplemented with 1% (v/v) penicillin and streptomycin. The medium was collected 48 hours post-transfection. 
Detached cells and cell debris was removed by centrifugation for 10 minutes at 4000 × g and medium was stored 
at − 20 °C. Before loading on SDS-PAGE gels, the media samples were concentrated using Amicon filters with 
30 kDa cut-off (Millipore) according to manufacturer’s instructions.
Protein-fragment complementation assay (PCA). HEK293T cells were plated at a density of 10 
000/well on 96-well plates with white walls (Perkin Elmer) and transiently transfected with 100 ng DNA per 
well of phGLuc(1 C) and phGLuc(2 C) expression plasmids or mock. The experiments were performed 48 h 
post-transfection: cells were washed with warm PBS and the media was replaced with Tau-GLuc conditioned 
or mock-conditioned media. Salubrinal was added to the medium where indicated. PCA luminescence signal 
detection was performed with Victor35 (Perkin Elmer) or Varioskan (Thermo Scientific) plate reader following 
well-by-well injection of the hGLuc substrate native coelenterazine (NanoLight Technology, USA). Eight replicate 
wells were analyzed per condition and at least three independent replicate experiments were performed.
Live-cell imaging. HEK293T cells were incubated for 4 hours with Tau-BiFC containing media, and for the 
last hour 10 μ M of TAT-TAMRA peptide (Anaspec) was added to the media where indicated. Just before imaging, 
cells were washed and media was replaced by phenol red-free DMEM supplemented with 15 mM Hepes buffer 
(Life Technologies). Imaging was performed with a Zeiss LSM 710 upright confocal and 63x water immersion 
objective at stable 37 °C temperature. Images were analyzed with ImageJ software.
Immunofluorescence imaging. Immunofluorescence imaging was performed as previously described30. 
Briefly, cells were grown on poly-L-lysine (Sigma) coated coverslips and fixed with 4% PFA in PBS for 20 minutes. 
Coverslips were washed with PBS and incubated for 1 hour with blocking buffer (1% BSA, 0.1% gelatin, 5% goat 
serum, 0.1% Triton X-100 and 0.05% Tween-20 in PBS; all from Sigma). Coverslips were then incubated with 
primary antibodies diluted 1:500 in 1% BSA and 0.1% gelatin in PBS overnight at +4 °C. The primary antibodies 
used were: Tau-5 (Invitrogen, mouse, 1:600), TIA1 (Santa Cruz, goat, 1:500), eIF3η (Santa Cruz, goat, 1:500), TTP 
(Santa Cruz, rabbit, 1:300), Rab7 (Cell Signaling, rabbit, 1:400), Rab5 (Novus Biological, rabbit, 1:500), Lamp2 
(Sigma, rabbit, 1:500) and AT8 (Thermo Scientific, mouse, 1:500). The Alexa-Fluor conjugated secondary anti-
bodies (Invitrogen) were incubated for 1 hour at room temperature in dilution 1:2000. The secondary antibodies 
used were 488-goat-anti-mouse, 568-donkey-anti-goat and 568-donkey-anti-rabbit. Nuclei were stained with 
Hoechst 33342 (Invitrogen) and coverslips mounted on microscope glasses with ProLong Gold anti-fade reagent 
(Invitrogen). Pictures were taken with a Zeiss AxioImager M1 epifluorescence microscope. Raw images were 
compiled using Adobe Photoshop. Quantifications from immunofluorescence images were done by counting 
stress granule-positive cells per total number of cells in randomly selected fields. Each field contained at least 50 
cells and at least three images per condition were analyzed.
Cell viability assays. Resazurin sodium salt (Sigma) was diluted in phenol red-free DMEM and added to the 
cells at the concentration of 100 μ M. Cells were incubated in +37 °C with 5% CO2 for 2 hours. Fluorescence was 
measured with Victor35 plate reader for 0.1 second at 530 nm excitation and 590 nm emission filters. Cell viability 
was calculated as percentage in comparison to a vehicle treated control.
LDH release was measured with CitoTox 96 Non-Radio Cytotoxicity Assay (Promega) according to manufac-
ture’s instructions. Absorbance was detected at 490 nm with Victor35 plate reader. Relative LDH release is a ratio 
of LDH in the media versus total LDH both in the cell and the media. Eight replicate wells analyzed per condition 
and at least three independent replicate experiments were performed.
qPCR – The gene silencing effect of the shTIA-1 plasmids was assessed by qPCR. Primers were designed with 
Geneious software and synthesized by Oligomer Oy (Helsinki, Finland). The primers used were: for TIA1 (forward) 
5′ -ACAGCAGAACAAAGGAACCC-3′ , (reversed) 5′ -TGTCTGTTTCCTTGCTGGTT-3′ ; for GAPDH, (for-
ward) 5′ -ACCCCTTCATTGACCTCAACTACATGG-3′ , (reversed) 5′ -ATCCACAGTCTTCTGGGTGGCA-3′ . 
RNeasy kit (Qiagen) was used to extract RNA from cell lysates, while RevertAid First Strand cDNA synthesis kit 
(Thermo Scientific) was used to translate RNA samples into cDNA, both according to manufacturer’s instruc-
tions. SYBR Green Maxima kit (Thermo Scientific) and RT-PCR cycler (Bio-Rad CFX95) were used to detect 
the relative mRNA amounts. Relative mRNA levels were calculated using the 2ΔΔCT method in Microsoft Excel.
Western blot. Western blotting was done as previously described49. Cells grown on poly-L-lysine-coated 
6-well plates and transfected with 3 μ g of total DNA per well were washed twice with ice-cold PBS 48 hours 
post-transfection, and extracted with extraction buffer [10 mM Tris-HCl, 1 mM EDTA, pH 6.8, 150 mM NaCl, 
1% Triton X-100, 0.25% Nonidet P-40, Protease and Phosphatase Inhibitor cocktail tablets (Roche Molecular 
Biochemicals), 1 μ M NaF]. Protein concentration of extracts was determined by BCA Protein Assay kit (Thermo 
Scientific) and equal amounts of cell lysates were resolved on 4–12% gradient Bis-Tris gels (Novex, Invitrogen) 
under reducing conditions. Proteins were transferred to PVDF membranes (GE Healthcare) by using sem-
idry blotting (Bio-Rad). Tau-5 antibody (Invitrogen), AT8 antibody (Thermo Scientific), GAPDH antibody 
(Millipore), horseradish peroxidase-conjugated secondary antibodies and ECL Western blotting detection rea-
gent (Thermo Scientific) were used to detect chemiluminescence signal.
Statistical analyses. Statistical analyses were performed in GraphPad Prism software using one-way 
ANOVA followed by Bonferroni post-tests. Error bars shown represent standard error of mean (SEM).
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